| Home >> About Us | |||
About Us Syndicatetrader.com is dedicated to provide investment professionals a better way to assess the risk and rewards of investing in IPO's and secondaries. We offer detailed research, in depth color, and a proprietary rating scale for each deal. With over 25 years of combined experience on the buyside, our team has the the industry knowledge and expertise to manage the syndicate calendar for you. Calendar In any given year there can upwards of 500+ syndicate related offerings. Fund managers understand that participating in the right offerings can help enhance returns, yet the time and personnel necessary to manage this process can be a problem. Funds often need to hire an additional analyst just to cover the syndicate calendar. SyndicateTrader.com is your in-house analyst for all IPO's and secondaries. We provide up to date detailed information on timing and overall interest on each offering. Filings
Our professionals comb through the databases (such as Edgar) to keep you abreast of all new filings within the last 30 days. This information is helpful to give our clients insight as to what will be coming down the pipe in subsequent months.
Company Profiles
Unlike many offerings available to investors, SyndicateTrader.com is much more than simply a calendar of upcoming deals. We provide profiles on each company, along w/ financial details and estimates (when available). We also provide a list of the most pertinent competitors to use for your evaluations.
Cold Deals
This is what we believe is a special bonus feature for subscribers. Though they may come around only a few times a quarter, or even throughout the year for that matter, investment professionals realize on of the most lucrative aspects to investing in IPO's and secondaries can arise from investing in "cold deals". These are the offerings that for whatever reason do not gain much attention at the time of the offering, or perhaps lose investor confidence early in their public lifecycle and break issue. We periodically write up our favorite "cold deals" that we believe are worth an additional look, and that we believe should outperform over an intermediate to longer term basis. |
|||